These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 952568

  • 21. Defibrinogenating enzymes.
    Bell WR.
    Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [Abstract] [Full Text] [Related]

  • 22. Enoxaparin for unstable angina and ancrod for cardiac surgery following heparin allergy.
    Smith RE, Townsend GE, Berry BR, Bowen T.
    Ann Pharmacother; 1996 May; 30(5):476-80. PubMed ID: 8740327
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis.
    Teasdale SJ, Zulys VJ, Mycyk T, Baird RJ, Glynn MF.
    Ann Thorac Surg; 1989 Nov; 48(5):712-3. PubMed ID: 2818066
    [Abstract] [Full Text] [Related]

  • 25. Soluble fibrin complex production and proteolysis during ancrod therapy.
    McKillop C, Edgar W, Prentice CR, Forbes CD.
    Scott Med J; 1975 May; 20(3):139-40. PubMed ID: 127379
    [No Abstract] [Full Text] [Related]

  • 26. Heparin-associated thrombocytopenia and thrombosis: optimal therapy with ancrod.
    Cole CW, Fournier LM, Bormanis J.
    Can J Surg; 1990 Jun; 33(3):207-10. PubMed ID: 2190683
    [Abstract] [Full Text] [Related]

  • 27. [Clinical experience with Arwin (author's transl)].
    Hess H, Keil-Kuri E, Marshall M.
    MMW Munch Med Wochenschr; 1975 Aug 08; 117(32-33):1317-20. PubMed ID: 819792
    [Abstract] [Full Text] [Related]

  • 28. Arwin in peripheral arterial circulatory disorders: controlled multicentre trials.
    Wolf GK.
    Eur J Clin Pharmacol; 1976 Mar 22; 09(5-6):387-92. PubMed ID: 786664
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A functional model of microvascular thrombosis.
    Davidson SF, Brantley SK, Talbot PJ, Das SK.
    Plast Reconstr Surg; 1990 Sep 22; 86(3):579-81. PubMed ID: 2385679
    [Abstract] [Full Text] [Related]

  • 31. Ancrod: understanding the agent.
    Illig KA, Ouriel K.
    Semin Vasc Surg; 1996 Dec 22; 9(4):303-14. PubMed ID: 8958607
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Prevention of acute experimental arterial thrombosis by defibrination.
    Haimov M, Danese C.
    Vasc Surg; 1973 Dec 22; 7(4):206-12. PubMed ID: 4762281
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of defibrination on tumor growth and response to chemotherapy.
    DeWys WD, Kwaan HC, Bathina S.
    Cancer Res; 1976 Oct 22; 36(10):3584-7. PubMed ID: 953985
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The nature of arterial healing following dextran treatment of experimental small artery trauma.
    Bloom WL, Bryant MF, Vincenzi RB, Vohman D, Brewer S.
    Surgery; 1975 Nov 22; 78(5):594-8. PubMed ID: 1188602
    [Abstract] [Full Text] [Related]

  • 40. New developments in acute anticoagulation therapy: what improvements over traditional heparin are on the horizon?
    Carter CJ.
    Postgrad Med; 1996 Jun 22; 99(6):129-36. PubMed ID: 8668626
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.